{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-270422","form_type":"8-K/A","ticker":"CDXS","cik":"0001200375","company_name":"CODEXIS, INC.","filed_at":"2023-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.436755+00:00","generated_at":"2026-06-08T22:03:55.009438+00:00","sec_items":["2.05","2.06"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Codexis revises restructuring costs; records $9.2M asset impairment on facility","bullets":["Workforce reduction of ~25% completed by Sept 30, 2023; actual severance costs $3.1M vs. expected $2.9M.","Non-cash goodwill impairment of $0.8M from discontinuing Biotherapeutics programs.","Non-cash asset impairment of $9.2M related to San Carlos facility previously assigned to Vaxcyte.","Operations streamlined by exiting Biotherapeutics development and consolidating to headquarters."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-270422","json":"https://secwatch.observer/filing/0001193125-23-270422.json","markdown":"https://secwatch.observer/filing/0001193125-23-270422.md","text":"https://secwatch.observer/filing/0001193125-23-270422.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1200375/000119312523270422/0001193125-23-270422-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1200375/000119312523270422/d490820d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T22:03:55.009438+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4658abc089deb0d03c4f36dc490413f661835425","claim":"CODEXIS, INC. announced a restructuring with charges of approximately $2.9 million affecting the Company (approximately 25%).","evidence_excerpt":"the Company expected to record an expense of approximately $2.9 million in connection with the payment of post-employment benefits to employees impacted by the workforce reduction, as well as the payment of other expenses such as related tax costs","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1200375/000119312523270422/0001193125-23-270422-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $2.9 million"},{"label":"Affected area","value":"the Company"},{"label":"Headcount","value":"approximately 25%"}],"fact_type":"restructuring_charge"},{"claim_id":"8063aa7b0655de36d45b375e1e22990acd336c36","claim":"CODEXIS, INC. announced a impairment with charges of approximately $0.8 million affecting Biotherapeutics.","evidence_excerpt":"the Company recorded one-time, non-cash charges, including approximately $0.8 million related to goodwill impairment from the decision to discontinue investment in its Biotherapeutics programs","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1200375/000119312523270422/0001193125-23-270422-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"impairment"},{"label":"Charge","value":"approximately $0.8 million"},{"label":"Affected area","value":"Biotherapeutics"}],"fact_type":"restructuring_charge"},{"claim_id":"f7068c881319e2929bd262d66777b5b2cb469f3e","claim":"CODEXIS, INC. announced a impairment with charges of approximately $9.2 million affecting San Carlos Facility.","evidence_excerpt":"approximately $9.2 million related to the impairment and write-down of assets related to the San Carlos Facility","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1200375/000119312523270422/0001193125-23-270422-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"impairment"},{"label":"Charge","value":"approximately $9.2 million"},{"label":"Affected area","value":"San Carlos Facility"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}